Astria Therapeutics, Inc. 2090.MU Stock
Astria Therapeutics, Inc. Price Chart
Astria Therapeutics, Inc. 2090.MU Financial and Trading Overview
| Astria Therapeutics, Inc. stock price | 4.74 EUR |
| Previous Close | 4.74 EUR |
| Open | 4.74 EUR |
| Bid | 0 EUR x N/A |
| Ask | 0 EUR x N/A |
| Day's Range | 4.74 - 4.74 EUR |
| 52 Week Range | 4.74 - 4.74 EUR |
| Volume | 108 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 132.81M EUR |
| Beta (5Y Monthly) | 0.916197 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -44.72 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
2090.MU Valuation Measures
| Enterprise Value | 15.6M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.1430295 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Astria Therapeutics, Inc. Stock Price History
| Beta (5Y Monthly) | 0.916197 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.74 EUR |
| 52 Week Low | 4.74 EUR |
| 50-Day Moving Average | 4.74 EUR |
| 200-Day Moving Average | 4.74 EUR |
2090.MU Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 28.03M |
| Float | 20.17M |
| Short Ratio | N/A |
| % Held by Insiders | 0.95% |
| % Held by Institutions | 81.71% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -19.38% |
| Return on Equity (ttm) | -29.71% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -47699000 EUR |
| Diluted EPS (ttm) | -44.77 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 213.33M EUR |
| Total Cash Per Share (mrq) | 7.61 EUR |
| Total Debt (mrq) | 794K EUR |
| Total Debt/Equity (mrq) | 0.38 EUR |
| Current Ratio (mrq) | 32.286 |
| Book Value Per Share (mrq) | 4.146 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -44227000 EUR |
| Levered Free Cash Flow (ttm) | -27201250 EUR |
Profile of Astria Therapeutics, Inc.
| Country | Germany |
| State | MA |
| City | Boston |
| Address | 75 State Street |
| ZIP | 02109 |
| Phone | 617 349 1971 |
| Website | https://www.astriatx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 45 |
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in clinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.
Q&A For Astria Therapeutics, Inc. Stock
What is a current 2090.MU stock price?
Astria Therapeutics, Inc. 2090.MU stock price today per share is 4.74 EUR.
How to purchase Astria Therapeutics, Inc. stock?
You can buy 2090.MU shares on the Munich exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Astria Therapeutics, Inc.?
The stock symbol or ticker of Astria Therapeutics, Inc. is 2090.MU.
Which industry does the Astria Therapeutics, Inc. company belong to?
The Astria Therapeutics, Inc. industry is Biotechnology.
How many shares does Astria Therapeutics, Inc. have in circulation?
The max supply of Astria Therapeutics, Inc. shares is 54.9M.
What is Astria Therapeutics, Inc. Price to Earnings Ratio (PE Ratio)?
Astria Therapeutics, Inc. PE Ratio is now.
What was Astria Therapeutics, Inc. earnings per share over the trailing 12 months (TTM)?
Astria Therapeutics, Inc. EPS is -44.72 EUR over the trailing 12 months.
Which sector does the Astria Therapeutics, Inc. company belong to?
The Astria Therapeutics, Inc. sector is Healthcare.